Gerald Commissiong, President and CEO of California-based Amarantus BioSciences, Inc. (OTC: AMBS), talks with the Opportunist’s Managing Editor Leslie Stone about his company’s groundbreaking work in the field of Parkinson’s disease. More than one million Americans are afflicted with Parkinson’s disease, and each year about 60,000 new cases are diagnosed—not including ... Read More